Geduld und Mut wird belohnt: Die Aktie von Genomic Health kann im heutigen Handel satte elf Prozent zulegen, das Diagnostik-Unternehmen…
Heres a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech stocks hitting 52-week…
NEW YORK , July 23, 2019 /PRNewswire/ -- Genomic Health Inc. (NASD: GHDX) will replace…
REDWOOD CITY, Calif. , June 20, 2019 /PRNewswire/ -- Genomic Health announced today that…
A good start to the year and no increased guidance mean slower growth ahead....…
After Genomics stellar first quarter, investors are getting jittery about growth in the second half....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Genomic Health (GHDX) delivered earnings and revenue surprises of 17.24% and 1.58%, respectively, for the quarter ended March 2019. Do…
REDWOOD CITY, Calif. , May 7, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported financial results…
The Zacks Analyst Blog Highlights: ANI, Kamada, Genomic Health and NewLink...…
Genomic Health (GHDX) continues to see positive developments for Oncotype DX Breast Recurrence Score tests....…
Having established a strong foothold in the U.S. market, Genomic Health (GHDX) is now making considerable expansion in the international…
Genomic Health (GHDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The cancer test maker is growing earnings much faster than revenue....…
Mit Spannung wurden die Zahlen des TSI-USA-Highflyers Genomic Health erwartet. Bereits in den Quartalen zuvor konnte der Konzern die Schätzungen…
Heres a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech stocks hitting 52-week…
GHDX earnings call for the period ending December 31, 2018....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Genomic Health (GHDX) delivered earnings and revenue surprises of 6.67% and 2.73%, respectively, for the quarter ended December 2018. Do…
REDWOOD CITY, Calif. , Feb. 20, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today…
Kulmbach (www.aktiencheck.de) - Genomic Health-Aktienanalyse von "Der Aktionär":
Stefan Sommer, Redakteur des Anlegermagazins "Der Aktionär", nimmt in einer aktuellen Aktienanalyse die…
Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4....…
REDWOOD CITY, Calif. , Feb. 13, 2019 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today…
Is (GHDX) Outperforming Other Medical Stocks This Year?...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Is (GHDX) Outperforming Other Medical Stocks This Year?...…
Having established a strong foothold in the U.S. market, Genomic Health (GHDX) is now expanding considerably in the international arena....…
REDWOOD CITY, Calif. , Dec. 19, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today…
Is (GHDX) Outperforming Other Medical Stocks This Year?...…
The alliance intends to develop an in vitro diagnostic (IVD) version of the Oncotype DX Genomic Prostate Score (GPS) test…
REDWOOD CITY, Calif. and MECHELEN, Belgium , Dec. 3, 2018 …
Um den gesamten Artikel unter inpublic.globenewswire.com zu lesen, klicken Sie bitte auf die Überschrift...…
REDWOOD CITY, Calif. , Nov. 19, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX)…
Record revenue and profits lead management to increase 2018 guidance....…
Genomic Health (GHDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid…
We are encouraged by the year-over-year rise in Genomic Healths (GHDX) revenues in Q3, driven by solid performances in the…
The genetic-testing leader kept up its impressive streak of profitable growth during the third quarter of 2018. It now expects…
Genomic Health (GHDX) delivered earnings and revenue surprises of 400.00% and 7.21%, respectively, for the quarter ended September 2018. Do…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
GHDX earnings call for the period ending September 30, 2018....…
REDWOOD CITY, Calif. , Nov. 6, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX) today reported…
REDWOOD CITY, Calif. , Oct. 30, 2018 /PRNewswire/ -- Genomic Health, Inc. (NASDAQ: GHDX)…
The genetic testing leaders year-to-date momentum continued for yet another month. Should investors be concerned by the streaks abrupt end…
Genomic Health (GHDX) forges ahead with the development of Oncotype DX Breast Recurrence Score test....…
REDWOOD CITY, Calif. , Oct. 9, 2018 /PRNewswire/ -- Genomic Health, Inc.…
Genomic Health (GHDX) continues to see increasing private coverage for the Oncotype DX GPS test....…
Genomic Health (GHDX) continues to see positive developments within the U.S. prostate cancer test business....…
REDWOOD CITY, Calif. , Sept. 28, 2018 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today…